Vandetanib

Vandetanib is a quinazoline derivative with methoxy, bromo-fluorophenylamino, and piperidinylmethoxy substituents. It functions as an antineoplastic agent and tyrosine kinase inhibitor, primarily employed as an active pharmaceutical ingredient in targeted cancer therapy.